Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Iben Lyskjær1,2,
- Neesha Kara2,
- Solange De Noon1,3,
- Christopher Davies1,3,
- Ana Maia Rocha1,3,
- Anna-Christina Strobl3,
- Inga Usher1,
- Craig Gerrand4,
- Sandra J Strauss5,
- Daniel Schrimpf6,
- Andreas von Deimling6,
- Stephan Beck2,* and
- Adrienne M Flanagan1,3,*,#
- 1Research Department of Pathology, University College London, London, UK
- 2Medical Genomics Research Group, University College London, London, UK
- 3Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, HA7 4LP UK
- 4Bone Tumour Unit, Royal National Orthopaedic Hospital, Stanmore, HA7 4LP, UK
- 5Department of Oncology, University College London, London, UK
- 6Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, and CCU Neuropathology, German Cancer Institute, Heidelberg, Germany
- ↵#Corresponding author; email: a.flanagan{at}ucl.ac.uk
↵* These authors contributed equally
Posted December 14, 2021.
Osteosarcoma: novel prognostic biomarkers using circulating and cell-free tumour DNA
